Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.7 USD | +4.40% | +5.47% | -9.57% |
May. 31 | Exelixis Insider Bought Shares Worth $8,733,955, According to a Recent SEC Filing | MT |
May. 20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.57% | 6.32B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Transcript : Exelixis, Inc. Presents at Oppenheimer 34th Annual Healthcare Life Sciences Conference, Feb-13-2024 12